Glenmede Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $258M | Sell |
|
|||||
|
2024
Q4 | $254M | Sell |
|
|||||
|
2024
Q3 | $316M | Sell |
|
|||||
|
2024
Q2 | $327M | Sell |
|
|||||
|
2024
Q1 | $286M | Sell |
|
|||||
|
2023
Q4 | $230M | Sell |
|
|||||
|
2023
Q3 | $220M | Sell |
|
|||||
|
2023
Q2 | $149M | Hold |
|
|||||
|
2023
Q1 | $149M | Sell |
|
|||||
|
2022
Q4 | $164M | Sell |
|
|||||
|
2022
Q3 | $147M | Buy |
|
|||||
|
2022
Q2 | $143M | Sell |
|
|||||
|
2022
Q1 | $129M | Sell |
|
|||||
|
2021
Q4 | $136M | Sell |
|
|||||
|
2021
Q3 | $116M | Sell |
|
|||||
|
2021
Q2 | $117M | Sell |
|
|||||
|
2021
Q1 | $100M | Buy |
|
|||||
|
2020
Q4 | $90.2M | Buy |
|
|||||
|
2020
Q3 | $73.3M | Sell |
|
|||||
|
2020
Q2 | $82.4M | Sell |
|
|||||
|
2020
Q1 | $68.2M | Hold |
|
|||||
|
2019
Q4 | $68.2M | Sell |
|
|||||
|
2019
Q3 | $91.4K | Sell |
|
|||||
|
2019
Q2 | $98.2K | Sell |
|
|||||
|
2019
Q1 | $125K | Sell |
|
|||||
|
2018
Q4 | $128K | Buy |
|
|||||
|
2018
Q3 | $116M | Sell |
|
|||||
|
2018
Q2 | $94M | Buy |
|
|||||
|
2018
Q1 | $60.5M | Hold |
|
|||||
|
2017
Q4 | $60.5M | Sell |
|
|||||
|
2017
Q3 | $62.5M | Sell |
|
|||||
|
2017
Q2 | $63M | Hold |
|
|||||
|
2017
Q1 | $63M | Sell |
|
|||||
|
2016
Q4 | $65.6M | Sell |
|
|||||
|
2016
Q3 | $72.7M | Sell |
|
|||||
|
2016
Q2 | $73M | Buy |
|
|||||
|
2016
Q1 | $65.3M | Buy |
|
|||||
|
2015
Q4 | $73.8M | Buy |
|
|||||
|
2015
Q3 | $72.4M | Sell |
|
|||||
|
2015
Q2 | $74.1M | Buy |
|
|||||
|
2015
Q1 | $64.2M | Sell |
|
|||||
|
2014
Q4 | $63.5M | Sell |
|
|||||
|
2014
Q3 | $60.6M | Sell |
|
|||||
|
2014
Q2 | $70.2M | Buy |
|
|||||
|
2014
Q1 | $60.5M | Buy |
|
|||||
|
2013
Q4 | $24.1M | Sell |
|
|||||
|
2013
Q3 | $23.9M | Sell |
|
|||||
|
2013
Q2 | $24.6M | Buy |
|